Effectiveness and Safety of Cefiderocol in Clinical Practice for Treatment of Patients with Gram-Negative Bacterial Infections: US Interim Results of the PROVE Study
Cefiderocol had similar clinical cure and response rates to previous retrospective studies and lower mortality. Cefiderocol was well tolerated in real-world settings in critically ill US patients with problematic Gram-negative pathogens.
Authors
- Cornelius J. Clancy (ORCID: https://orcid.org/0000-0003-1505-4119)
- Bin Cai (ORCID: https://orcid.org/0000-0003-0410-8820)
- Laurence Gozalo
- Sean Nguyen (ORCID: https://orcid.org/0009-0001-4779-2100)
- Oliver A Cornely
- Stephen W. Marcella
Institutions
- University of Pittsburgh (US)
- University of Cologne (DE)
- German Center for Infection Research (DE)
- Shionogi (United States) (US)
- Cologne Excellence Cluster on Cellular Stress Responses in Aging Associated Diseases (DE)
- Genesis Research Institute (JP)
- University Hospital Cologne (DE)
Publication Details
- Journal
- Infection and Drug Resistance
- Published
- 2024-10-01
- DOI
- https://doi.org/10.2147/idr.s475462
- Citations
- 16
- Primary Topic
- Antibiotic Use and Resistance
- Type
- article
- Field-Weighted Citation Impact
- 4.77
Funders
- Shionogi